Donoghue Forlines LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Donoghue Forlines LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $309,947 - $547,375	-7,823 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $27,767 - $39,439	-478 Reduced 5.76%	7,823 $519,000
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $484,612 - $705,252	8,301 New	8,301 $518,000
Q1 2020 May 12, 2020	SELL	$20.56 - $63.12 $694,660 - $2.13 Million	-33,787 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$28.14 - $73.01 $950,766 - $2.47 Million	33,787 New	33,787 $2.14 Million

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.